Hepatitis Monthly

Published by: Kowsar

No Correlation Between Interleukin-10 Gene Promoter Polymorphisms and Hepatitis B Virus Infection Outcome

Masoomeh Sofian 1 , Ebrahim Kalantar 2 , Arezoo Aghakhani 3 , Soudabeh Hosseini 2 , Mohammad Banifazl 4 , Ali Eslamifar 3 , Ali jourabchi 5 , Ali Asghar Farazi 1 and Amitis Ramezani 3 , *
Authors Information
1 Tuberculosis and Pediatric Infectious Research Center, Arak University of Medical Sciences, Arak, IR Iran
2 Gholhak Laboratory, Tehran, IR Iran
3 Department of Clinical Research, Pasteur Institute of Iran, Tehran, IR Iran
4 Iranian Society for Support Patients With Infectious Disease, Tehran, IR Iran
5 Department of Infectious Disease, Arak University of Medical Sciences, Arak, IR Iran
Article information
  • Hepatitis Monthly: May 01, 2013, 13 (5); e8803
  • Published Online: May 19, 2013
  • Article Type: Research Article
  • Received: October 27, 2012
  • Revised: January 28, 2013
  • Accepted: April 7, 2013
  • DOI: 10.5812/hepatmon.8803

To Cite: Sofian M, Kalantar E, Aghakhani A, Hosseini S, Banifazl M, et al. No Correlation Between Interleukin-10 Gene Promoter Polymorphisms and Hepatitis B Virus Infection Outcome, Hepat Mon. 2013 ; 13(5):e8803. doi: 10.5812/hepatmon.8803.

Copyright © 2013, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A, Banifazl M, Taeb J, et al. Association of human leukocyte antigen polymorphism with outcomes of hepatitis B virus infection. J Gastroenterol Hepatol. 2008; 23(11): 1716-21[DOI][PubMed]
  • 2. Ramezani A, Aghakhani A, Kalantar E, Banifazl M, Eslamifar A, Velayati AA. HLA-A *3303* and *3301 predispose patients to persistent hepatitis B infection. J Gastrointestin Liver Dis. 2009; 18(1): 117-8[PubMed]
  • 3. Yang G, Liu J, Han S, Xie H, Du R, Yan Y, et al. Association between hepatitis B virus infection and HLA-DRB1 genotyping in Shaanxi Han patients in northwestern China. Tissue Antigens. 2007; 69(2): 170-5[DOI][PubMed]
  • 4. Ben-Ari Z, Mor E, Papo O, Kfir B, Sulkes J, Tambur AR, et al. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol. 2003; 98(1): 144-50[DOI][PubMed]
  • 5. Miyazoe S, Hamasaki K, Nakata K, Kajiya Y, Kitajima K, Nakao K, et al. Influence of interleukin-10 gene promoter polymorphisms on disease progression in patients chronically infected with hepatitis B virus. Am J Gastroenterol. 2002; 97(8): 2086-92[DOI][PubMed]
  • 6. Mosman TR, Frank JD. Advances in Immunology. 1994; : 1-26[DOI]
  • 7. Gao QJ, Liu DW, Zhang SY, Jia M, Wang LM, Wu LH, et al. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol. 2009; 15(44): 5610-9[PubMed]
  • 8. Wang S, Huang D, Sun S, Ma W, Zhen Q. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis B to interferon alfa. Virol J. 2011; 8: 28[DOI][PubMed]
  • 9. Turner DM, Williams DM, Sankaran D, Lazarus M, Sinnott PJ, Hutchinson IV. An investigation of polymorphism in the interleukin-10 gene promoter. Eur J Immunogenet. 1997; 24(1): 1-8[PubMed]
  • 10. Eskdale J, Keijsers V, Huizinga T, Gallagher G. Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun. 1999; 1(2): 151-5[DOI][PubMed]
  • 11. Cheong JY, Cho SW, Hwang IL, Yoon SK, Lee JH, Park CS, et al. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J Gastroenterol Hepatol. 2006; 21(7): 1163-9[DOI][PubMed]
  • 12. Shin HD, Park BL, Kim LH, Jung JH, Kim JY, Yoon JH, et al. Interleukin 10 haplotype associated with increased risk of hepatocellular carcinoma. Hum Mol Genet. 2003; 12(8): 901-6[PubMed]
  • 13. Wu JF, Ni YH, Lin YT, Lee TJ, Hsu SH, Chen HL, et al. Human interleukin-10 genotypes are associated with different precore/core gene mutation patterns in children with chronic hepatitis B virus infection. J Pediatr. 2011; 158(5): 808-13[DOI][PubMed]
  • 14. Zhang PA, Li Y, Yang XS. [Associated study on interleukin 10 gene promoter polymorphisms related to hepatitis B virus infection in Chinese Han population]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006; 23(4): 410-4[PubMed]
  • 15. Lu YL, Wu X, Huang HL, Dai LC. Allele polymorphisms of interleukin-10 and hepatitis B, C virus infection. Chin Med J (Engl). 2010; 123: 1338-1344
  • 16. Pestka S, Krause CD, Sarkar D, Walter MR, Shi Y, Fisher PB. Interleukin-10 and related cytokines and receptors. Annu Rev Immunol. 2004; 22: 929-79[DOI][PubMed]
  • 17. Truelove AL, Oleksyk TK, Shrestha S, Thio CL, Goedert JJ, Donfield SM, et al. Evaluation of IL10, IL19 and IL20 gene polymorphisms and chronic hepatitis B infection outcome. Int J Immunogenet. 2008; 35(3): 255-64[DOI][PubMed]
  • 18. Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P. Polymorphic haplotypes of the interleukin-10 5' flanking region determine variable interleukin-10 transcription and are associated with particular phenotypes of juvenile rheumatoid arthritis. Arthritis Rheum. 1999; 42(6): 1101-8[PubMed]
  • 19. Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa. Hepatology. 1999; 30(2): 526-30[DOI][PubMed]
  • 20. Peng XM, Huang YS, Ma HH, Gu L, Xie QF, Gao ZL. Interleukin-10 promoter polymorphisms are associated with the mode and sequel of HBeAg seroconversion in patients with chronic hepatitis B virus infection. Liver Int. 2006; 26(3): 326-33[DOI][PubMed]
  • 21. Zhang TC, Pan FM, Zhang LZ, Gao YF, Zhang ZH, Gao J, et al. A meta-analysis of the relation of polymorphism at sites -1082 and -592 of the IL-10 gene promoter with susceptibility and clearance to persistent hepatitis B virus infection in the Chinese population. Infection. 2011; 39(1): 21-7[DOI][PubMed]
  • 22. Zhu QR, Ge YL, Gu SQ, Yu H, Wang JS, Gu XH, et al. Relationship between cytokines gene polymorphism and susceptibility to hepatitis B virus intrauterine infection. Chin Med J (Engl). 2005; 118(19): 1604-9[PubMed]
  • 23. Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, et al. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol. 2005; 42(4): 505-10[DOI][PubMed]
  • 24. Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW. Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A. 1998; 95(16): 9465-70[PubMed]
  • 25. Ahmadabadi BN, Hassanshahi G, Arababadi MK, Leanza C, Kennedy D. The IL-10 promoter polymorphism at position -592 is correlated with susceptibility to occult HBV infection. Inflammation. 2012; 35(3): 818-21[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments